Shreeshant P.

Shreeshant P. has a diverse background in strategy and consulting, particularly within international markets. They served as a Director and Team Lead at Pfizer from 2025 to 2022, leading strategy efforts across international markets outside the US, and previously held roles at Palladium and the Clinton Health Access Initiative focusing on health financing. Their early career included positions as an Investment Associate at AFIG FUNDS and as a Senior Accountant at KPMG Australia. Shreeshant earned a Bachelor of Commerce from The University of Western Australia, a Graduate Diploma in Chartered Accounting, and an MBA from Georgetown University with a 3.93 GPA.